CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Budapest, Hungary and 202 other locations
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...
Phase 2, Phase 3
Budapest, Hungary and 82 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Budapest, Hungary and 162 other locations
study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer...
Phase 1, Phase 2
Budapest, Hungary and 61 other locations
cell, pancreatic and biliary duct, endometrial, melanoma and urothelial tumors. This study contains two parts, single agent dose e...
Phase 1
Komárno, Slovakia and 40 other locations
This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....
Phase 1, Phase 2
Budapest, Hungary and 76 other locations
is to evaluate the safety of acasunlimab (also known as GEN1046) as monotherapy and in combination therapies in patients with malignant solid tumors...
Phase 1, Phase 2
Törökbálint, Hungary and 56 other locations
in women with mismatch repair deficient (dMMR) advanced or recurrent endometrial carcinoma who have not previously been treated with prior s...
Phase 3
Budapest, Hungary and 194 other locations
The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.
Phase 1, Phase 2
Budapest, Hungary and 113 other locations
for an analysis called cervical cytology (if applicable)* take an endometrial biopsy, a small piece of tissue from the lining of the womb (c...
Phase 3
Szekesfehervar, Hungary and 103 other locations
Clinical trials
Research sites
Resources
Legal